Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation: A Phase 2 Study.
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02467-19
Full Text
Open PDFAbstract
Available in full text
Date
February 3, 2020
Authors
Publisher
American Society for Microbiology